Interchange Capital Partners’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $101K | Sell |
19,930
-5,787
| -23% | -$29.3K | 0.02% | 277 |
|
|
2025
Q1 | $136K | Sell |
25,717
-5,106
| -17% | -$27K | 0.04% | 264 |
|
|
2024
Q4 | $202K | Sell |
30,823
-4,664
| -13% | -$30.6K | 0.07% | 235 |
|
|
2024
Q3 | $234K | Buy |
35,487
+907
| +3% | +$5.98K | 0.08% | 231 |
|
|
2024
Q2 | $268K | Buy |
34,580
+2,349
| +7% | +$18.2K | 0.1% | 204 |
|
|
2024
Q1 | $332K | Buy |
32,231
+9,438
| +41% | +$97.4K | 0.22% | 111 |
|
|
2023
Q4 | $224K | Buy |
+22,793
| New | +$224K | 0.17% | 136 |
|